Rufiga Shari Abidin: Multi Organ Complications Detailed in COVID 19 Vaccine Adverse Event Study
Rufiga Shari Abidin, Lecturer at Hasanuddin University, shared a post on LinkedIn:
“This paper lists adverse events caused by COVID-19 vaccines across multiple organs with examples of cases.
Adverse events described include myopericarditis, thrombocytopenia, anemia, cerebral venous sinus thrombosis, leukocytoclastic vasculitis, chiblain-like lesions, herpes zoster, pityriasis rosea, immunoglobulin nephropathy, tubulointerstitial nephritis, acute disseminated encephalomyelitis, hyponatremia, memory loss, idiopathic facial paralysis and rhabdomyolysis.
The iteration that ‘the number of adverse events are relatively low’ and that ‘vaccination benefits still outweigh the risks’, appears as something the authors and authors of other papers have to swallow and repeat in order to be able to share their data and findings, where content and data are hinting the contrary.
Even just one adverse events presented in this paper should have put a stop to the clinical trials, stop vaccine roll-out to the public, and led to the COVID-19 vaccine withdrawal from the market.
The vaccine injured should not just be reduced to numbers and represented in an underestimated statistical calculations.”
Title: Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases
Authors: Harshini Yaamika, Divya Muralidas, Karthikeyan Elumalai
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 08:36Bahram Alamdary Badlou: Why Jak Inhibitors Demand Careful Monitoring In Chronic Inflammation Treatment?
-
Nov 10, 2026, 08:16Uyiekpen Ima-Edomwonyi: Why Autoimmune Inflammation Demands Early Vigilance?
-
Nov 10, 2026, 06:20Vida Shafti: Can AI Help Us Predict Thrombosis before it Happens in Assisted Reproduction?
-
Nov 10, 2026, 06:11Michaël Prüfer: Treatment of Varicose Veins with Laser Endoveineux Total
-
Nov 10, 2026, 05:55Sandhya Selvakumar: Guide to Stroke Classification and Rehabilitation
-
Nov 9, 2026, 22:47Avirup Guha: Early Immune Responses to Androgen Deprivation Therapy and Coronary Plaque Progression
-
Nov 9, 2026, 22:42Angela Forsyth: Joining Novo Nordisk as Medical Liaison for the Ohio Valley Region
-
Nov 9, 2026, 22:36Vladimir Otasevic: Presenting Thromboprophylaxis and Treatment of VTE in Patients With Malignancy
-
Nov 9, 2026, 22:28Dragoș Claudiu Popescu: Corticosteroid Exposure and Thrombotic Risk in ITP